Glaukos Corporation Glaukos Corporation

Glaukos Corporation

GKOS

Clasificación en acciones #2020
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Precio por acción
$173.73
Capitalización bursátil
$10.25B
Cambio (1 día)
4.16%
Cambio (1 año)
118.61%
País
US
Comercio Glaukos Corporation (GKOS)

Categoría

Healthcare
Historial de desdoblamientos de acciones de Glaukos Corporation (GKOS)
La acción Glaukos Corporation (símbolo: GKOS) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Oct 20, 2026.
Una acción GKOS comprada antes de Oct 20, 2026 equivaldría hoy a 0 acciones GKOS.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
9 x285
US
7 x127
IE
9 x162
US
2 x4
US
0 -
DE